Diabetes Monitoring Devices Market, by Product Type, Indication, Approach, End User, and Region - Global Trends, and Forecast to 2025

Diabetes Monitoring Devices Market, by Product Type, Indication, Approach, End User, and Region - Global Trends, and Forecast to 2025

Diabetes refers to a group of metabolic diseases in which a person suffers from high or low levels of blood sugar levels for a prolonged period. Most common symptoms of diabetes includes increased thirst, increased urination, and increased hunger. Diabetes is one the prime diseases that carries risk of chronic cardiovascular diseases and can also lead to life-threatening events such as cardiac arrests or heart failure. Thus, it is a preliminary requirement for diabetic patient to monitor blood glucose levels at frequent time intervals, which can be achieved by diabetes monitoring devices.
Market Dynamics
The major factors contributing the growth of global diabetes monitoring devices market are increasing number of patients suffering from diabetes across the world. According to the World Health Organization (WHO) 2014, diabetes is one of the diseases that has dire consequences on health, which affected around 422 million people across the world in 2014. Moreover, it has resulted in approximately 1.6 million deaths in 2015, which increases the demand for management solutions. Moreover, obesity is one of the other prominent factor that leads to the cause of diabetes in most of the obese patients. According to The National Institute of Diabetes and Digestive and Kidney Diseases, Statistics on Diabetes 2015, over 90% of patients suffering from diabetes were reported to be obese. However, the high cost of these devices coupled with the calibration errors associated with these devices are hindering the market growth. The research and development in the area of continuous glucose monitors are expected to provide growth opportunities for new and established market players to capitalize upon and witness growth in terms of sales, as these devices are in high demand due to the hassle free diabetes monitoring records that they provide in real time at a go.
Key features of the study:

This report provides in-depth analysis of diabetes monitoring devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global diabetes monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study Bayer Healthcare AG, Medtronic, Dexcom, Sanofi S.A., Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the diabetes monitoring devices market

Detailed Segmentation:

Global Diabetes Monitoring Devices Market, By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

Global Diabetes Monitoring Devices Market, By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

Global Diabetes Monitoring Devices Market, By Approach:

Invasive
Non-Invasive

Global Diabetes Monitoring Devices Market, By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

Global Diabetes Monitoring Devices Market, By Geography:

North America

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

U.S.
Canada

Latin America

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Self-Monitoring Glucose Devices
Continuous Glucose Monitoring Devices

By Indication:

Type-I Diabetes
Type-II Diabetes
Gestational Diabetes

By Approach:

Invasive
Non-Invasive

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Centers
Others

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Bayer AG *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Roche Diagnostics
Johnson & Johnson
Medtronic plc
Dexcom, Inc.
Abbott Laboratories Ltd.
MediWise
Arkay, Inc.
Cnoga Medical
Bigfoot Biomedical
Sanofi S.A.

 “*” marked represents similar segmentation in other categories in the respective section.